| # | Drug | Count |
|---|---|---|
| 0 | RANITIDINE | 56 |
| 1 | METHOTREXATE SODIUM | 53 |
| 2 | METHOTREXATE | 50 |
| 3 | ADALIMUMAB | 42 |
| 4 | INFLIXIMAB | 42 |
| 5 | ASPIRIN | 39 |
| 6 | ASPIRIN 325 MG | 39 |
| 7 | ASPIRIN 81 MG | 39 |
| 8 | FUROSEMIDE | 37 |
| 9 | VALSARTAN | 33 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ALOGLIPTIN | 7 | 0.0020 |
| 1 | PANCRELIPASE | 31 | 0.0008 |
| 2 | DURVALUMAB | 15 | 0.0007 |
| 3 | BICALUTAMIDE | 9 | 0.0006 |
| 4 | URSODIOL | 12 | 0.0005 |
| 5 | RANITIDINE HYDROCHLORIDE | 26 | 0.0005 |
| 6 | SITAGLIPTIN AND METFORMIN HYDROCHLORIDE | 10 | 0.0005 |
| 7 | GEMCITABINE HYDROCHLORIDE | 23 | 0.0004 |
| 8 | URSOSIOL | 8 | 0.0004 |
| 9 | EXENATIDE | 20 | 0.0004 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 81 |
| 1 | Nonsteroidal Anti-inflammatory Drug [EPC] | 70 |
| 2 | Tumor Necrosis Factor Blocker [EPC] | 66 |
| 3 | Folate Analog Metabolic Inhibitor [EPC] | 50 |
| 4 | GLP-1 Receptor Agonist [EPC] | 49 |
| 5 | Proton Pump Inhibitor [EPC] | 48 |
| 6 | Angiotensin 2 Receptor Blocker [EPC] | 43 |
| 7 | Loop Diuretic [EPC] | 39 |
| 8 | Platelet Aggregation Inhibitor [EPC] | 39 |
| 9 | Thalidomide Analog [EPC] | 30 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Classical Complement Pathway Inhibitor [EPC] | 1 | 0.0031 |
| 1 | Programmed Death Ligand-1 Blocker [EPC] | 15 | 0.0007 |
| 2 | Bile Acid [EPC] | 12 | 0.0005 |
| 3 | Neonatal Fc Receptor Blocker [EPC] | 2 | 0.0005 |
| 4 | Hypoxia-inducible Factor Prolyl Hydroxylase Inhibitor [EPC] | 1 | 0.0004 |
| 5 | SLAMF7-directed Immunostimulatory Antibody [EPC] | 2 | 0.0004 |
| 6 | Glinide [EPC] | 3 | 0.0003 |
| 7 | Thrombopoietin Receptor Agonist [EPC] | 5 | 0.0003 |
| 8 | Vitamin D2 Analog [EPC] | 2 | 0.0003 |
| 9 | Amyloid Beta-directed Antibody [EPC] | 1 | 0.0003 |